Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Jun Hata Last modified date:2020.01.09

Associate Professor / Department of Epidemiology and Public Health / Department of Basic Medicine / Faculty of Medical Sciences


Papers
1. NCD Risk Factor Collaboration (NCD-RisC)., A century of trends in adult human height., Elife, 10.7554/eLife.13410, 5, e13410, 2016.07.
2. Kojima I, Ninomiya T, Hata J, Fukuhara M, Hirakawa Y, Mukai N, Yoshida D, Kitazono T, Kiyohara Y., A low ankle brachial index is associated with an increased risk of cardiovascular disease: the Hisayama study., J Atheroscler Thromb, 21, 9, 966-973, 2014.01.
3. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y., A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction., Nat Genet, 39, 2, 212-217, 2007.02.
4. Tanaka M, Honda T, Yamakage H, Hata J, Yoshida D, Hirakawa Y, Shibata M, Inoue T, Kusakabe T, Satoh-Asahara N, Ninomiya T., A potential novel pathological implication of serum soluble triggering receptor expressed on myeloid cell 2 in insulin resistance in a general Japanese population: The Hisayama study., Diabetes Res Clin Pract, 10.1016/j.diabres.2018.10.007, 146, 225-232, 2018.12.
5. Kiyohara T, Kamouchi M, Kumai Y, Ninomiya T, Hata J, Yoshimura S, Ago T, Okada Y, Kitazono T; Fukuoka Stroke Registry Investigators., ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack., Stroke, 10.1161/STROKEAHA.113.003077, 45, 2, 418-425, 2014.02.
6. Shiwa Y, Hachiya T, Furukawa R, Ohmomo H, Ono K, Kudo H, Hata J, Hozawa A, Iwasaki M, Matsuda K, Minegishi N, Satoh M, Tanno K, Yamaji T, Wakai K, Hitomi J, Kiyohara Y, Kubo M, Tanaka H, Tsugane S, Yamamoto M, Sobue K, et al., Adjustment of Cell-Type Composition Minimizes Systematic Bias in Blood DNA Methylation Profiles Derived by DNA Collection Protocols., PLoS One, 10.1371/journal.pone.0147519, 11, 1, e0147519, 2016.01.
7. Wakisaka Y, Matsuo R, Hata J, Kuroda J, Kitazono T, Kamouchi M, Ago T; Fukuoka Stroke Registry Investigators., Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry., Cerebrovasc Dis, 10.1159/000453625, 43, 1-2, 82-89, 2017.01.
8. Takae K, Hata J, Ohara T, Yoshida D, Shibata M, Mukai N, Hirakawa Y, Kishimoto H, Tsuruya K, Kitazono T, Kiyohara Y, Ninomiya T., Albuminuria Increases the Risks for Both Alzheimer Disease and Vascular Dementia in Community-Dwelling Japanese Elderly: The Hisayama Study., J Am Heart Assoc, 10.1161/JAHA.117.006693, 7, 2, e006693, 2018.01.
9. Usui T, Ninomiya T, Nagata M, Doi Y, Hata J, Fukuhara M, Kiyohara Y., Albuminuria as a risk factor for peripheral arterial disease in a general population: the Hisayama study., J Atheroscler Thromb, 18, 8, 705-712, 2011.01.
10. Mukai N, Ohara T, Hata J, Hirakawa Y, Yoshida D, Kishimoto H, Koga M, Nakamura U, Kitazono T, Kiyohara Y, Ninomiya T., Alternative Measures of Hyperglycemia and Risk of Alzheimer's Disease in the Community: The Hisayama Study., J Clin Endocrinol Metab, 10.1210/jc.2017-00439, 102, 8, 3002-3010, 2017.08.
11. Doi Y, Ninomiya T, Hirakawa Y, Takahashi O, Mukai N, Hata J, Iwase M, Kitazono T, Oike Y, Kiyohara Y., Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study., Diabetes Care, 10.2337/dc12-0166, 36, 1, 98-100, 2013.01.
12. Usui T, Ninomiya T, Nagata M, Takahashi O, Doi Y, Hata J, Fukuhara M, Kitazono T, Oike Y, Kiyohara Y., Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study., Circ J, 77, 9, 2311-2317, 2013.01.
13. Kondo H, Ninomiya T, Hata J, Hirakawa Y, Yonemoto K, Arima H, Nagata M, Tsuruya K, Kitazono T, Kiyohara Y., Angiotensin I-converting enzyme gene polymorphism enhances the effect of hypercholesterolemia on the risk of coronary heart disease in a general Japanese population: the hisayama study., J Atheroscler Thromb, 10.5551/jat.24166, 22, 4, 390-403, 2015.01.
14. Ohara T, Ninomiya T, Kubo M, Hirakawa Y, Doi Y, Hata J, Iwaki T, Kanba S, Kiyohara Y., Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study., J Am Geriatr Soc, 10.1111/j.1532-5415.2011.03405.x, 59, 6, 1074-1079, 2011.06.
15. Ohara T, Honda T, Hata J, Yoshida D, Mukai N, Hirakawa Y, Shibata M, Kishimoto H, Kitazono T, Kanba S, Ninomiya T., Association Between Daily Sleep Duration and Risk of Dementia and Mortality in a Japanese Community., J Am Geriatr Soc, 10.1111/jgs.15446, 66, 10, 1911-1918, 2018.10.
16. Hirabayashi N, Hata J, Ohara T, Mukai N, Nagata M, Shibata M, Gotoh S, Furuta Y, Yamashita F, Yoshihara K, Kitazono T, Sudo N, Kiyohara Y, Ninomiya T., Association Between Diabetes and Hippocampal Atrophy in Elderly Japanese: The Hisayama Study., Diabetes Care, 10.2337/dc15-2800, 39, 9, 1543-1549, 2016.09.
17. Inaishi J, Hirakawa Y, Horikoshi M, Akiyama M, Higashioka M, Yoshinari M, Hata J, Mukai N, Kamatani Y, Momozawa Y, Kubo M, Ninomiya T., Association Between Genetic Risk and Development of Type 2 Diabetes in a General Japanese Population: The Hisayama Study., J Clin Endocrinol Metab, 10.1210/jc.2018-01782, 104, 8, 3213-3222, 2019.08.
18. Matsuo R, Yamaguchi Y, Matsushita T, Hata J, Kiyuna F, Fukuda K, Wakisaka Y, Kuroda J, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators., Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke., Stroke, 10.1161/STROKEAHA.117.018132, 48, 11, 3049-3056, 2017.11.
19. Umehara K, Mukai N, Hata J, Hirakawa Y, Ohara T, Yoshida D, Kishimoto H, Kitazono T, Hoka S, Kiyohara Y, Ninomiya T., Association Between Serum Vitamin D and All-Cause and Cause-Specific Death in a General Japanese Population - The Hisayama Study., Circ J, 10.1253/circj.CJ-16-0954, 81, 9, 1315-1321, 2017.08.
20. Hata J, Ohara T, Katakura Y, Shimizu K, Yamashita S, Yoshida D, Honda T, Hirakawa Y, Shibata M, Sakata S, Kitazono T, Kuhara S, Ninomiya T., Association Between Serum Beta-Alanine and Risk of Dementia., Am J Epidemiol, 10.1093/aje/kwz116, 188, 9, 1637-1645, 2019.09, We examined the association between serum concentrations of β-alanine, a metabolite of carnosine and anserine, and the risk of dementia in a general population of elderly Japanese persons. In 2007, 1,475 residents of Hisayama,
Japan, aged 60–79 years and without dementia were divided into 4 groups according to quartiles of serum β-alanine concentrations (quartile 1, lowest; quartile 4, highest) and followed for a median of 5.3 years. During
follow-up, 117 subjects developed all-cause dementia (Alzheimer in 77 cases and vascular dementia in 31). The risk of all-cause dementia decreased with increasing serum β-alanine levels after adjustment for potential confounding
factors (quartile 2, hazard ratio (HR) = 0.73 (95% confidence interval (CI): 0.45, 1.18); quartile 3, HR = 0.50 (95% CI: 0.28, 0.89); quartile 4, HR = 0.50 (95% CI: 0.27, 0.92); P = 0.01 for trend). A similar inverse association
was observed for Alzheimer disease (quartile 2, HR = 0.78 (95% CI: 0.44, 1.38); quartile 3, HR = 0.53 (95% CI: 0.26, 1.06); quartile 4, HR = 0.53 (95% CI: 0.25, 1.10); P = 0.04 for trend) but not for vascular dementia. We found
that higher serum β-alanine levels were significantly associated with lower risks of all-cause dementia and Alzheimer disease. Because serum β-alanine levels reflect intakes of carnosine/anserine, higher intakes of carnosine/anserine
might be beneficial for the prevention of dementia..
21. Hashimoto S, Yasuda M, Fujiwara K, Ueda E, Hata J, Hirakawa Y, Ninomiya T, Sonoda KH., Association between Axial Length and Myopic Maculopathy: The Hisayama Study., Ophthalmol Retina, 10.1016/j.oret.2019.04.023, 3, 10, 867-873, 2019.10.
22. Hirakawa Y, Ninomiya T, Mukai N, Doi Y, Hata J, Fukuhara M, Iwase M, Kitazono T, Kiyohara Y., Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study., Am J Epidemiol, 10.1093/aje/kws178, 176, 10, 856-864, 2012.11.
23. Ninomiya T, Nagata M, Hata J, Hirakawa Y, Ozawa M, Yoshida D, Ohara T, Kishimoto H, Mukai N, Fukuhara M, Kitazono T, Kiyohara Y., Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study., Atherosclerosis, 10.1016/j.atherosclerosis.2013.09.023, 231, 2, 261-267, 2013.12.
24. Shibata M, Ohara T, Yoshida D, Hata J, Mukai N, Kawano H, Kanba S, Kitazono T, Ninomiya T., Association between the ratio of serum arachidonic acid to eicosapentaenoic acid and the presence of depressive symptoms in a general Japanese population: the Hisayama Study., J Affect Disord, 10.1016/j.jad.2018.05.004, 237, 73-79, 2018.09.
25. Kudo K, Hata J, Matsumoto K, Shundo Y, Fukuyama S, Inoue H, Kitazono T, Kiyohara Y, Ninomiya T, Nakanishi Y., Association of Airflow Limitation With Carotid Atherosclerosis in a Japanese Community - The Hisayama Study., Circ J, 10.1253/circj.CJ-16-1305, 81, 12, 1846-1853, 2017.11.
26. Matsuzaki T, Sasaki K, Hata J, Hirakawa Y, Fujimi K, Ninomiya T, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T., Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study., Neurology, 10.1212/WNL.0b013e31822e145d, 77, 11, 1068-1075, 2011.09.
27. Kiyuna F, Sato N, Matsuo R, Kamouchi M, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators., Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke., JAMA Netw Open, 10.1001/jamanetworkopen.2018.2953, 1, 5, e182953, 2018.09.
28. Mukai N, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, Hotta T, Koga M, Nakamura U, Kang D, Kitazono T, Kiyohara Y., Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study., Cardiovasc Diabetol, 10.1186/s12933-015-0247-7, 14, 84-84, 2015.06.
29. Matsushita T, Umeno J, Hirakawa Y, Yonemoto K, Ashikawa K, Amitani H, Ninomiya T, Hata J, Doi Y, Kitazono T, Iida M, Nakamura Y, Kiyohara Y, Kubo M., Association study of the polymorphisms on chromosome 12p13 with atherothrombotic stroke in the Japanese population., J Hum Genet, 10.1038/jhg.2010.45, 55, 7, 473-476, 2010.07.
30. Delcourt C, Zheng D, Chen X, Hackett M, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Woodward M, Huang Y, Robinson T, Lavados PM, Lindley RI, Stapf C, Davies L, Chalmers J, Anderson CS, Sato S; INTERACT Investigators., Associations with health-related quality of life after intracerebral haemorrhage: pooled analysis of INTERACT studies., J Neurol Neurosurg Psychiatry, 10.1136/jnnp-2016-314414, 88, 1, 70-75, 2017.01.
31. Yonemoto K, Doi Y, Hata J, Ninomiya T, Fukuhara M, Ikeda F, Mukai N, Iida M, Kiyohara Y., Body mass index and stroke incidence in a Japanese community: the Hisayama study., Hypertens Res, 10.1038/hr.2010.220, 34, 2, 274-279, 2011.02.
32. Ninomiya T, Kojima I, Doi Y, Fukuhara M, Hirakawa Y, Hata J, Kitazono T, Kiyohara Y., Brachial-ankle pulse wave velocity predicts the development of cardiovascular disease in a general Japanese population: the Hisayama Study., J Hypertens, 10.1097/HJH.0b013e32835c5c23, 31, 3, 477-483, 2013.03.
33. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, Doi Y, Okubo K, Oishi Y, Shikata K, Yonemoto K, Maebuchi D, Ibayashi S, Iida M., C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study., Stroke, 37, 1, 27-32, 2006.01.
34. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration., Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment., Lancet Diabetes Endocrinol, 10.1016/S2213-8587(14)70102-0, 2, 8, 634-647, 2014.08.
35. Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators., Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation., Cerebrovasc Dis, 10.1159/000445723, 42, 3-4, 196-204, 2016.01.
36. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M., Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study., Kidney Int, 68, 1, 228-236, 2005.07.
37. Kawamura R, Doi Y, Osawa H, Ninomiya T, Hata J, Yonemoto K, Tanizaki Y, Iida M, Makino H, Kiyohara Y., Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study., Nephrol Dial Transplant, 10.1093/ndt/gfq155, 25, 10, 3236-3240, 2010.10.
38. Matsuo R, Ago T, Kamouchi M, Kuroda J, Kuwashiro T, Hata J, Sugimori H, Fukuda K, Gotoh S, Makihara N, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T., Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study., BMC Neurol, 10.1186/1471-2377-13-32, 13, 32-32, 2013.04.
39. Peters SAE, Wang X, Lam TH, Kim HC, Ho S, Ninomiya T, Knuiman M, Vaartjes I, Bots ML, Woodward M; Asia Pacific Cohort Studies Collaboration., Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: results from the Asia Pacific Cohort Studies Collaboration., BMJ Open, 10.1136/bmjopen-2017-019335, 8, 3, e019335, 2018.03.
40. Ikeda F, Shikata K, Hata J, Fukuhara M, Hirakawa Y, Ohara T, Mukai N, Nagata M, Yoshida D, Yonemoto K, Esaki M, Kitazono T, Kiyohara Y, Ninomiya T., Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study., J Epidemiol, 26, 12, 629-636, 2016.12.
41. Hata J, Doi Y, Ninomiya T, Fukuhara M, Ikeda F, Mukai N, Hirakawa Y, Kitazono T, Kiyohara Y., Combined effects of smoking and hypercholesterolemia on the risk of stroke and coronary heart disease in Japanese: the Hisayama study., Cerebrovasc Dis, 10.1159/000324392, 31, 5, 477-484, 2011.01.
42. NCD Risk Factor Collaboration (NCD-RisC) ., Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants., Int J Epidemiol.
43. White IR, Rapsomaniki E; Emerging Risk Factors Collaboration., Covariate-adjusted measures of discrimination for survival data., Biom J, 10.1002/bimj.201400061, 57, 4, 592-613, 2015.07.
44. Mukai N, Doi Y, Ninomiya T, Hata J, Hirakawa Y, Fukuhara M, Iwase M, Kiyohara Y., Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study., Diabet Med, 10.1111/j.1464-5491.2011.03378.x, 29, 1, 99-106, 2012.01.
45. Yoshida D, Ohara T, Hata J, Shibata M, Hirakawa Y, Honda T, Uchida K, Takasugi S, Kitazono T, Kiyohara Y, Ninomiya T., Dairy consumption and risk of functional disability in an elderly Japanese population: the Hisayama Study., Am J Clin Nutr, 10.1093/ajcn/nqz040, 109, 6, 1664-1671, 2019.06.
46. Fukuda K, Kai H, Kamouchi M, Hata J, Ago T, Nakane H, Imaizumi T, Kitazono T; FSR Investigators.; steering committee of the Fukuoka Stroke Registry included., Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry., Stroke, 10.1161/STROKEAHA.115.009076, 46, 7, 1832-1839, 2015.07.
47. Oishi E, Ohara T, Sakata S, Fukuhara M, Hata J, Yoshida D, Shibata M, Ohtsubo T, Kitazono T, Kiyohara Y, Ninomiya T., Day-to-Day Blood Pressure Variability and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study., Circulation, 10.1161/CIRCULATIONAHA.116.025667, 136, 6, 516-525, 2017.08.
48. Hatabe Y, Shibata M, Ohara T, Oishi E, Yoshida D, Honda T, Hata J, Kanba S, Kitazono T, Ninomiya T., Decline in Handgrip Strength From Midlife to Late-Life is Associated With Dementia in a Japanese Community: The Hisayama Study., J Epidemiol, 10.2188/jea.JE20180137, 30, 1, 15-23, 2020.01.
49. Kubo M, Kiyohara Y, Ninomiya T, Tanizaki Y, Yonemoto K, Doi Y, Hata J, Oishi Y, Shikata K, Iida M., Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population., Neurology, 66, 10, 1539-1544, 2006.05.
50. Sato S, Delcourt C, Zhang S, Arima H, Heeley E, Zheng D, Al-Shahi Salman R, Stapf C, Tzourio C, Robinson T, Lindley RI, Chalmers J, Anderson CS; INTERACT2 Investigators., Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage., Cerebrovasc Dis, 10.1159/000442532, 41, 1-2, 80-86, 2016.01.
51. Arima H, Yonemoto K, Doi Y, Ninomiya T, Hata J, Tanizaki Y, Fukuhara M, Matsumura K, Iida M, Kiyohara Y., Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study., Hypertens Res, 10.1038/hr.2009.161, 32, 12, 1119-1122, 2009.12.
52. Iida M, Ikeda F, Hata J, Hirakawa Y, Ohara T, Mukai N, Yoshida D, Yonemoto K, Esaki M, Kitazono T, Kiyohara Y, Ninomiya T., Development and validation of a risk assessment tool for gastric cancer in a general Japanese population., Gastric Cancer, 10.1007/s10120-017-0768-8, 21, 3, 383-390, 2018.05.
53. Honda T, Yoshida D, Hata J, Hirakawa Y, Ishida Y, Shibata M, Sakata S, Kitazono T, Ninomiya T., Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study., Atherosclerosis, 10.1016/j.atherosclerosis.2018.10.014, 279, 38-44, 2018.12.
54. Osawa H, Doi Y, Makino H, Ninomiya T, Yonemoto K, Kawamura R, Hata J, Tanizaki Y, Iida M, Kiyohara Y., Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study., Cardiovasc Diabetol, 10.1186/1475-2840-8-60, 8, 60-60, 2009.11.
55. Ozawa M, Yoshida D, Hata J, Ohara T, Mukai N, Shibata M, Uchida K, Nagata M, Kitazono T, Kiyohara Y, Ninomiya T., Dietary Protein Intake and Stroke Risk in a General Japanese Population: The Hisayama Study., Stroke, 10.1161/STROKEAHA.116.016059, 48, 6, 1478-1486, 2017.06.
56. Miyazaki M, Doi Y, Ikeda F, Ninomiya T, Hata J, Uchida K, Shirota T, Matsumoto T, Iida M, Kiyohara Y., Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study., Gastric Cancer, 10.1007/s10120-011-0092-7, 15, 2, 162-169, 2012.04.
57. Shimazaki Y, Akifusa S, Takeshita T, Shibata Y, Doi Y, Hata J, Ninomiya T, Hirakawa Y, Kiyohara Y, Yamashita Y., Effectiveness of the salivary occult blood test as a screening method for periodontal status., J Periodontol, 10.1902/jop.2010.100304, 82, 4, 581-587, 2011.04.
58. Arima H, Anderson C, Omae T, Woodward M, Hata J, Murakami Y, Macmahon S, Neal B, Chalmers J; PROGRESS Collaborative Group., Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial., Stroke, 10.1161/STROKEAHA.110.606764, 42, 8, 2339-2341, 2011.08.
59. Nakane H, Kamouchi M, Hata J, Ibayashi S, Kusuda K, Omae T, Nagao T, Ago T, Kitazono T; EMINENT Study Investigators., Effects of hydrochlorothiazide on oxidative stress and pulse pressure in hypertensive patients with chronic stroke: the EMINENT study., Intern Med, 10.2169/internalmedicine.54.2631, 54, 6, 573-577, 2015.01.
60. Hata J, Arima H, Zoungas S, Fulcher G, Pollock C, Adams M, Watson J, Joshi R, Kengne AP, Ninomiya T, Anderson C, Woodward M, Patel A, Mancia G, Poulter N, MacMahon S, Chalmers J, Neal B; ADVANCE Collaborative Group., Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial., PLoS One, 10.1371/journal.pone.0055807, 8, 2, e55807, 2013.01.
61. Hata J, Arima H, Rothwell PM, Woodward M, Zoungas S, Anderson C, Patel A, Neal B, Glasziou P, Hamet P, Mancia G, Poulter N, Williams B, Macmahon S, Chalmers J; ADVANCE Collaborative Group., Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial., Circulation, 10.1161/CIRCULATIONAHA.113.002717, 128, 12, 1325-1334, 2013.09.
62. Sekita A, Arima H, Ninomiya T, Ohara T, Doi Y, Hirakawa Y, Fukuhara M, Hata J, Yonemoto K, Ga Y, Kitazono T, Kanba S, Kiyohara Y., Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study., BMC Public Health, 10.1186/1471-2458-13-862, 13, 862-862, 2013.09.
63. Zheng D, Sato S, Arima H, Heeley E, Delcourt C, Cao Y, Chalmers J, Anderson CS; INTERACT2 Investigators., Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage., Am J Kidney Dis, 10.1053/j.ajkd.2016.01.020, 68, 1, 94-102, 2016.07.
64. Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y., Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population., J Clin Endocrinol Metab, 10.1210/jc.2007-2819, 93, 9, 3425-3429, 2008.09.
65. Wakugawa Y, Sugimori H, Nakane H, Hata J, Irie K, Kitazono T, Iida M., Flow volume and cross-sectional area of the extracranial vertebral arteries and its relation to vascular lesions or anatomical variations in the posterior circulation., Ultrasound Med Biol, 10.1016/j.ultrasmedbio.2009.01.006, 35, 7, 1068-1075, 2009.07.
66. Hashimoto S, Yasuda M, Ninomiya T, Hata J, Yoshida D, Tahara-Asakuma T, Hirakawa Y, Arakawa S, Fujiwara K, Kiyohara Y, Ishibashi T., Foveal and Macular Thickness in a Japanese Population: The Hisayama Study., Ophthalmic Epidemiol, 10.3109/09286586.2015.1136651, 23, 3, 202-208, 2016.06.
67. Hata J, Matsuda K, Ninomiya T, Yonemoto K, Matsushita T, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Iida M, Kiyohara Y, Nakamura Y, Kubo M., Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction., Hum Mol Genet, 16, 6, 630-639, 2007.03.
68. Matsushita T, Ashikawa K, Yonemoto K, Hirakawa Y, Hata J, Amitani H, Doi Y, Ninomiya T, Kitazono T, Ibayashi S, Iida M, Nakamura Y, Kiyohara Y, Kubo M., Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke., Hum Mol Genet, 10.1093/hmg/ddp582, 19, 6, 1137-1146, 2010.03.
69. Franceschini N, Giambartolomei C, de Vries PS, Finan C, Bis JC, Huntley RP, Lovering RC, Tajuddin SM, Winkler TW, Graff M, Kavousi M, Dale C, Smith AV, Hofer E, van Leeuwen EM, Nolte IM, Lu L, Scholz M, Sargurupremraj M, Pitkテ、nen N, Franzテゥn O, Joshi PK, et al., GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes., Nat Commun, 10.1038/s41467-018-07340-5, 9, 1, 5141-5141, 2018.12.
70. Ogata T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Ago T, Sugimori H, Inoue T, Kitazono T; Fukuoka Stroke Registry., Gastrointestinal bleeding in acute ischemic stroke: recent trends from the fukuoka stroke registry., Cerebrovasc Dis Extra, 10.1159/000365245, 4, 2, 156-164, 2014.07.
71. Hachiya T, Kamatani Y, Takahashi A, Hata J, Furukawa R, Shiwa Y, Yamaji T, Hara M, Tanno K, Ohmomo H, Ono K, Takashima N, Matsuda K, Wakai K, Sawada N, Iwasaki M, Yamagishi K, Ago T, Ninomiya T, Fukushima A, Hozawa A, Minegishi N, et al., Genetic Predisposition to Ischemic Stroke: A Polygenic Risk Score., Stroke, 10.1161/STROKEAHA.116.014506, 48, 2, 253-258, 2017.02.
72. Fujiwara K, Yasuda M, Hata J, Hirakawa Y, Hashimoto S, Ueda E, Iwase A, Araie M, Yoshitomi T, Ninomiya T, Sonoda KH., Glucose Tolerance Levels and Circumpapillary Retinal Nerve Fiber Layer Thickness in a General Japanese Population: The Hisayama Study., Am J Ophthalmol, 10.1016/j.ajo.2019.03.031, 205, 140-146, 2019.09.
73. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, Kanba S, Kiyohara Y., Glucose tolerance status and risk of dementia in the community: the Hisayama study., Neurology, 10.1212/WNL.0b013e31822f0435, 77, 12, 1126-1134, 2011.09.
74. Emerging Risk Factors Collaboration., Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Willeit J, Njテクlstad I, et al., Glycated hemoglobin measurement and prediction of cardiovascular disease., JAMA, 10.1001/jama.2014.1873, 311, 12, 1225-1233, 2014.03.
75. Emerging Risk Factors Collaboration., Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Willeit J, Njテクlstad I, et al., Glycated hemoglobin measurement and prediction of cardiovascular disease., JAMA, 10.1001/jama.2014.1873, 311, 12, 1225-1233, 2014.03.
76. Ikeda F, Doi Y, Ninomiya T, Hirakawa Y, Mukai N, Hata J, Shikata K, Yoshida D, Matsumoto T, Kitazono T, Kiyohara Y., Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study., Cardiovasc Diabetol, 10.1186/1475-2840-12-164, 12, 164-164, 2013.11.
77. Gotoh S, Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Fukuhara M, Ikeda F, Ago T, Kitazono T, Kiyohara Y., Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study., Atherosclerosis, 10.1016/j.atherosclerosis.2015.07.014, 242, 1, 199-204, 2015.09.
78. Ishitsuka K, Kamouchi M, Hata J, Fukuda K, Matsuo R, Kuroda J, Ago T, Kuwashiro T, Sugimori H, Nakane H, Kitazono T; FSR Investigators., High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry., Hypertension, 10.1161/HYPERTENSIONAHA.113.02189, 63, 1, 54-60, 2014.01.
79. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y., High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study., Arterioscler Thromb Vasc Biol, 10.1161/ATVBAHA.107.157164, 28, 7, 1385-1391, 2008.07.
80. Sato S, Heeley E, Arima H, Delcourt C, Hirakawa Y, Pamidimukkala V, Li Z, Tao Q, Xu Y, Hennerici MG, Robinson T, Tzourio C, Lindley RI, Chalmers J, Anderson CS; INTERACT Investigators., Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al., Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2., J Neurol Neurosurg Psychiatry, 10.1136/jnnp-2014-309870, 86, 12, 1319-1323, 2015.12.
81. Ikeda F, Doi Y, Yonemoto K, Ninomiya T, Kubo M, Shikata K, Hata J, Tanizaki Y, Matsumoto T, Iida M, Kiyohara Y., Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study., Gastroenterology, 10.1053/j.gastro.2008.12.045, 136, 4, 1234-1241, 2009.04.
82. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, Nakamura H, Hata J, Oishi Y, Kato I, Hirakata H, Iida M., Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study., Am J Kidney Dis, 44, 3, 437-445, 2004.09.
83. Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y., Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: The Hisayama Study., Diabetes, 56, 11, 2829-2833, 2007.11.
84. Arima H, Tanizaki Y, Yonemoto K, Doi Y, Ninomiya T, Hata J, Fukuhara M, Matsumura K, Iida M, Kiyohara Y., Impact of blood pressure levels on different types of stroke: the Hisayama study., J Hypertens, 10.1097/HJH.0b013e328330e882, 27, 12, 2437-2443, 2009.12.
85. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M, Iida M, Kiyohara Y., Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study., Stroke, 10.1161/STROKEAHA.109.564708, 41, 2, 203-209, 2010.02.
86. Fukuhara M, Arima H, Ninomiya T, Hata J, Yonemoto K, Doi Y, Hirakawa Y, Matsumura K, Kitazono T, Kiyohara Y., Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study., J Hypertens, 10.1097/HJH.0b013e328351d380, 30, 5, 893-900, 2012.05.
87. Mukai N, Doi Y, Ninomiya T, Hata J, Yonemoto K, Iwase M, Iida M, Kiyohara Y., Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study., Diabetes Care, 10.2337/dc09-0896, 32, 12, 2288-2293, 2009.12.
88. Matsuo R, Ago T, Hata J, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T, Kamouchi M; FSR Investigators., Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry., J Stroke Cerebrovasc Dis, 10.1016/j.jstrokecerebrovasdis.2013.11.011, 23, 6, 1356-1361, 2014.07.
89. Ishikawa H, Wakisaka Y, Matsuo R, Makihara N, Hata J, Kuroda J, Ago T, Kitayama J, Nakane H, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators., Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry., Cerebrovasc Dis, 42, 5-6, 395-403, 2016.01.
90. Fujiwara K, Yasuda M, Ninomiya T, Hata J, Hashimoto S, Yoshitomi T, Kiyohara Y, Ishibashi T., Insulin Resistance Is a Risk Factor for Increased Intraocular Pressure: The Hisayama Study., Invest Ophthalmol Vis Sci, 10.1167/iovs.15-16766, 56, 13, 7983-7987, 2015.12.
91. Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators., Insulin resistance and clinical outcomes after acute ischemic stroke., Neurology, 10.1212/WNL.0000000000005358, 90, 17, LEFT(Y91,FIND("-",Y91)-1)-MID(Y91,FIND("-",Y91)+1,10), 2018.04.
92. Gotoh S, Doi Y, Hata J, Ninomiya T, Mukai N, Fukuhara M, Kamouchi M, Kitazono T, Kiyohara Y., Insulin resistance and the development of cardiovascular disease in a Japanese community: the Hisayama study., J Atheroscler Thromb, 19, 11, 977-985, 2012.01.
93. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T., Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study., Neurology, 10.1212/WNL.0b013e3181eee25f, 75, 9, 764-770, 2010.08.
94. Nakamura A, Ago T, Kamouchi M, Hata J, Matsuo R, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators., Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry., Stroke, 10.1161/STROKEAHA.113.002523, 44, 11, 3239-3242, 2013.11.
95. Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, Hackett ML, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Robinson T, Davies L, Lavados PM, Lindley RI, Stapf C, Chalmers J, Anderson CS; INTERACT2 Investigators., Intracerebral hemorrhage location and outcome among INTERACT2 participants., Neurology, 10.1212/WNL.0000000000003771, 88, 15, 1408-1414, 2017.04.
96. Matsuo R, Kamouchi M, Fukuda H, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators., Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry., PLoS One, 10.1371/journal.pone.0110444, 9, 10, e110444, 2014.10.
97. Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, Tanizaki Y, Ibayashi S, Iida M, Kiyohara Y., LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study., Stroke, 10.1161/STROKEAHA.108.529537, 40, 2, 382-388, 2009.02.
98. Matsushita T, Kubo M, Yonemoto K, Ninomiya T, Ashikawa K, Liang B, Hata J, Doi Y, Kitazono T, Ibayashi S, Iida M, Kiyohara Y, Nakamura Y., Lack of association between variations of PDE4D and ischemic stroke in the Japanese population., Stroke, 10.1161/STROKEAHA.108.527408, 40, 4, 1245-1251, 2009.04.
99. Ogata T, Matsuo R, Kiyuna F, Hata J, Ago T, Tsuboi Y, Kitazono T, Kamouchi M; FSR Investigators., Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation., J Am Heart Assoc, 10.1161/JAHA.117.006402, 6, 8, e006402, 2017.08.
100. Fujiwara K, Yasuda M, Hata J, Yoshida D, Kishimoto H, Hashimoto S, Yoshitomi T, Ninomiya T, Sonoda KH., Long-term regular exercise and intraocular pressure: the Hisayama Study., Graefes Arch Clin Exp Ophthalmol, 10.1007/s00417-019-04441-9, 257, 11, 2461-2469, 2019.11.
101. Yonemoto K, Honda T, Kishimoto H, Yoshida D, Hata J, Mukai N, Shibata M, Hirakawa Y, Ninomiya T, Kumagai S., Longitudinal Changes of Physical Activity and Sedentary Time in the Middle-Aged and Older Japanese Population: The Hisayama Study., J Phys Act Health, 10.1123/jpah.2017-0701, 16, 2, 165-171, 2019.02.
102. Zheng D, Arima H, Sato S, Gasparrini A, Heeley E, Delcourt C, Lo S, Huang Y, Wang J, Stapf C, Robinson T, Lavados P, Chalmers J, Anderson CS; INTERACT2 investigators., Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study., PLoS One, 10.1371/journal.pone.0149040, 11, 2, e0149040, 2016.02.
103. Hata A, Doi Y, Ninomiya T, Mukai N, Hirakawa Y, Hata J, Ozawa M, Uchida K, Shirota T, Kitazono T, Kiyohara Y., Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study., Diabet Med, 10.1111/dme.12250, 30, 12, 1487-1494, 2013.12.
104. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects)., Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G., Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1ツキ8 million participants., Lancet, 10.1016/S0140-6736(13)61836-X, 383, 9921, 970-983, 2014.03.
105. Ohara T, Ninomiya T, Hata J, Ozawa M, Yoshida D, Mukai N, Nagata M, Iwaki T, Kitazono T, Kanba S, Kiyohara Y., Midlife and Late-Life Smoking and Risk of Dementia in the Community: The Hisayama Study., J Am Geriatr Soc, 10.1111/jgs.13794, 63, 11, 2332-2339, 2015.11.
106. Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, Hata J, Kanba S, Iwaki T, Kiyohara Y., Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study., Hypertension, 10.1161/HYPERTENSIONAHA.110.163055, 58, 1, 22-28, 2011.07.
107. Kishimoto H, Hata J, Ninomiya T, Nemeth H, Hirakawa Y, Yoshida D, Kumagai S, Kitazono T, Kiyohara Y., Midlife and late-life handgrip strength and risk of cause-specific death in a general Japanese population: the Hisayama Study., J Epidemiol Community Health, 10.1136/jech-2013-203611, 68, 7, 663-668, 2014.07.
108. Ozawa M, Ohara T, Ninomiya T, Hata J, Yoshida D, Mukai N, Nagata M, Uchida K, Shirota T, Kitazono T, Kiyohara Y., Milk and dairy consumption and risk of dementia in an elderly Japanese population: the Hisayama Study., J Am Geriatr Soc, 10.1111/jgs.12887, 62, 7, 1224-1230, 2014.07.
109. Sakata S, Hata J, Fukuhara M, Yonemoto K, Mukai N, Yoshida D, Kishimoto H, Ohtsubo T, Kitazono T, Kiyohara Y, Ninomiya T., Morning and Evening Blood Pressures Are Associated With Intima-Media Thickness in a General Population縲- The Hisayama Study., Circ J, 10.1253/circj.CJ-16-1306, 81, 11, 1647-1653, 2017.10.
110. Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Parテゥ G, O'Donnell M, Ago T, et al., Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis., Circulation, 10.1161/CIRCULATIONAHA.118.038439, 139, 2, 295-298, 2019.01.
111. Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, et al., Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes., Nat Genet, 10.1038/s41588-018-0058-3, 50, 4, 524-537, 2018.04.
112. Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y., N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study., Arterioscler Thromb Vasc Biol, 10.1161/ATVBAHA.111.223669, 31, 12, 2997-3003, 2011.12.
113. Nagata T, Ohara T, Hata J, Sakata S, Furuta Y, Yoshida D, Honda T, Hirakawa Y, Ide T, Kanba S, Kitazono T, Tsutsui H, Ninomiya T., NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study., J Am Heart Assoc, 10.1161/JAHA.118.011652, 8, 17, e011652, 2019.09.
114. NCD Risk Factor Collaboration ., National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries., Int J Epidemiol.
115. Imamura T, Doi Y, Ninomiya T, Hata J, Nagata M, Ikeda F, Mukai N, Hirakawa Y, Yoshida D, Fukuhara M, Kitazono T, Kiyohara Y., Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study., Atherosclerosis, 10.1016/j.atherosclerosis.2014.01.005, 233, 2, 343-348, 2014.04.
116. Honda T, Kishimoto H, Mukai N, Hata J, Yoshida D, Hirakawa Y, Shibata M, Ohara T, Kumagai S, Ninomiya T., Objectively measured sedentary time and diabetes mellitus in a general Japanese population: The Hisayama Study., J Diabetes Investig, 10.1111/jdi.12968, 10, 3, 809-816, 2019.05.
117. Sato S, Arima H, Heeley E, Hirakawa Y, Delcourt C, Lindley RI, Robinson T, Huang Y, Morgenstern L, Stapf C, Wang J, Chalmers J, Anderson CS; INTERACT2 Investigators., Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial., Cerebrovasc Dis, 10.1159/000434690, 40, 3-4, 114-120, 2015.01.
118. Arima H, Heeley E, Delcourt C, Hirakawa Y, Wang X, Woodward M, Robinson T, Stapf C, Parsons M, Lavados PM, Huang Y, Wang J, Chalmers J, Anderson CS; INTERACT2 Investigators.; INTERACT2 Investigators., Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2., Neurology, 10.1212/WNL.0000000000001205, 84, 5, 464-471, 2015.02.
119. Shikata K, Ninomiya T, Yonemoto K, Ikeda F, Hata J, Doi Y, Fukuhara M, Matsumoto T, Iida M, Kitazono T, Kiyohara Y., Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study., Scand J Gastroenterol, 10.3109/00365521.2012.658855, 47, 6, 669-675, 2012.06.
120. Torisu K, Zhang X, Nonaka M, Kaji T, Tsuchimoto D, Kajitani K, Sakumi K, Torisu T, Chida K, Sueishi K, Kubo M, Hata J, Kitazono T, Kiyohara Y, Nakabeppu Y., PKCη deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice., Genes Cells, 10.1111/gtc.12402, 21, 10, 1030-1048, 2016.10.
121. Chen T, Kishimoto H, Honda T, Hata J, Yoshida D, Mukai N, Shibata M, Ninomiya T, Kumagai S., Patterns and Levels of Sedentary Behavior and Physical Activity in a General Japanese Population: The Hisayama Study., J Epidemiol, 10.2188/jea.JE20170012, 28, 5, 260-265, 2018.05.
122. Takeuchi K, Matsumoto K, Furuta M, Fukuyama S, Takeshita T, Ogata H, Suma S, Shibata Y, Shimazaki Y, Hata J, Ninomiya T, Nakanishi Y, Inoue H, Yamashita Y., Periodontal status and lung function decline in the community: the Hisayama study., Sci Rep, 10.1038/s41598-018-31610-3, 8, 1, 13354-13354, 2018.09.
123. Takeuchi K, Matsumoto K, Furuta M, Fukuyama S, Takeshita T, Ogata H, Suma S, Shibata Y, Shimazaki Y, Hata J, Ninomiya T, Nakanishi Y, Inoue H, Yamashita Y., Periodontitis Is Associated with Chronic Obstructive Pulmonary Disease., J Dent Res, 10.1177/0022034519833630, 98, 5, 534-540, 2019.05.
124. Matsuo R, Ago T, Hata J, Wakisaka Y, Kuroda J, Kuwashiro T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators., Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study., PLoS One, 10.1371/journal.pone.0156790, 11, 6, e0156790, 2016.06.
125. Wakisaka Y, Ago T, Kamouchi M, Kuroda J, Matsuo R, Hata J, Gotoh S, Isomura T, Awano H, Suzuki K, Fukuda K, Okada Y, Kiyohara Y, Ooboshi H, Kitazono T; REBIOS Investigators., Plasma S100A12 is associated with functional outcome after ischemic stroke: Research for Biomarkers in Ischemic Stroke., J Neurol Sci, 10.1016/j.jns.2014.02.031, 340, 1-2, 75-79, 2014.05.
126. Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, et al., Polymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: the Fukuoka Stroke Registry and the Hisayama study., Eur J Neurol, 10.1111/j.1468-1331.2008.02105.x, 15, 5, 481-486, 2008.05.
127. Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, et al., Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population. The Fukuoka Stroke Registry and the Hisayama Study., Cerebrovasc Dis, 10.1159/000121342, 25, 5, 417-422, 2008.01.
128. Kuroda J, Matsuo R, Yamaguchi Y, Sato N, Kamouchi M, Hata J, Wakisaka Y, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators., Poor glycemic control and posterior circulation ischemic stroke., Neurol Clin Pract, 10.1212/CPJ.0000000000000608, 9, 2, 129-139, 2019.04.
129. Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M, Mancia G, Mogensen CE, Poulter N, Chalmers J; ADVANCE Collaborative Group., Prediction of kidney-related outcomes in patients with type 2 diabetes., Am J Kidney Dis, 10.1053/j.ajkd.2012.04.025, 60, 5, 770-778, 2012.11.
130. Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y, Fukushima Y, Sugimori H, Kitazono T; FSR Investigators., Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry., Stroke, 10.1161/STROKEAHA.111.617415, 42, 10, 2788-2794, 2011.10.
131. Fujiwara K, Yasuda M, Hata J, Oshima Y, Hashimoto S, Yoshitomi T, Kiyohara Y, Ishibashi T, Ninomiya T, Sonoda KH., Prevalence and Risk Factors for Polypoidal Choroidal Vasculopathy in a General Japanese Population: The Hisayama Study., Semin Ophthalmol, 10.1080/08820538.2018.1506483, 33, 6, 813-819, 2018.01.
132. Yoshida D, Ninomiya T, Doi Y, Hata J, Fukuhara M, Ikeda F, Mukai N, Kiyohara Y., Prevalence and causes of functional disability in an elderly general population of Japanese: the Hisayama study., J Epidemiol, 22, 3, 222-229, 2012.01.
133. Tanaka A, Hata J, Akamatsu N, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Ohara T, Mizuno T, Tsuji S, Kitazono T, Ninomiya T., Prevalence of adult epilepsy in a general Japanese population: The Hisayama study., Epilepsia Open, 10.1002/epi4.12295, 4, 1, 182-186, 2019.01.
134. Yubi T, Hata J, Ohara T, Mukai N, Hirakawa Y, Yoshida D, Gotoh S, Hirabayashi N, Furuta Y, Ago T, Kitazono T, Kiyohara Y, Ninomiya T., Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community., Neurol Clin Pract, 10.1212/CPJ.0000000000000464, 8, 3, 223-231, 2018.06.
135. Carcel C, Sato S, Zheng D, Heeley E, Arima H, Yang J, Wu G, Chen G, Zhang S, Delcourt C, Lavados P, Robinson T, Lindley RI, Wang X, Chalmers J, Anderson CS; Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Investigators., Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies., Crit Care Med, 10.1097/CCM.0000000000001628, 44, 7, 1388-1394, 2016.07.
136. Ohkuma T, Woodward M, Jun M, Muntner P, Hata J, Colagiuri S, Harrap S, Mancia G, Poulter N, Williams B, Rothwell P, Chalmers J; ADVANCE Collaborative Group., Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study., Hypertension, 10.1161/HYPERTENSIONAHA.117.09359, 70, 2, 461-468, 2017.08.
137. Doi Y, Ninomiya T, Hata J, Yonemoto K, Arima H, Kubo M, Tanizaki Y, Iwase M, Iida M, Kiyohara Y., Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study., Stroke, 10.1161/STROKEAHA.108.531319, 40, 4, 1187-1194, 2009.04.
138. Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T; FSR Investigators., Proteinuria and clinical outcomes after ischemic stroke., Neurology, 10.1212/WNL.0b013e318259e110, 78, 24, 1909-1915, 2012.06.
139. Maebuchi D, Arima H, Doi Y, Ninomiya T, Yonemoto K, Tanizaki Y, Kubo M, Hata J, Matsumura K, Iida M, Kiyohara Y., QT interval prolongation and the risks of stroke and coronary heart disease in a general Japanese population: the Hisayama study., Hypertens Res, 10.1038/hr.2010.88, 33, 9, 916-921, 2010.09.
140. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Wang J, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J; INTERACT2 Investigators., Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage., N Engl J Med, 10.1056/NEJMoa1214609, 368, 25, 2355-2365, 2013.06.
141. Higashioka M, Hirakawa Y, Kawamura R, Honda T, Hata J, Yoshida D, Takata Y, Kitazono T, Osawa H, Ninomiya T., Ratios of serum eicosapentaenoic acid to arachidonic acid and docosahexaenoic acid to arachidonic acid were inversely associated with serum resistin levels: The Hisayama Study., J Diabetes Investig.
142. Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, Oda Y, Kitazono T, Ninomiya T., Reduced Estimated GFR and Cardiac Remodeling: A Population-Based Autopsy Study., Am J Kidney Dis, 10.1053/j.ajkd.2019.02.013, 74, 3, 373-381, 2019.09.
143. Hillis GS, Hata J, Woodward M, Perkovic V, Arima H, Chow CK, Zoungas S, Patel A, Poulter NR, Mancia G, Williams B, Chalmers J., Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus., J Am Heart Assoc, 10.1161/JAHA.112.002832, 1, 5, e002832, 2012.10.
144. NCD Risk Factor Collaborationツ(NCD-RisC)., Rising rural body-mass index is the main driver of the global obesity epidemic in adults., Nature, 10.1038/s41586-019-1171-x, 569, 7755, 260-264, 2019.05.
145. Hata J, Nagai A, Hirata M, Kamatani Y, Tamakoshi A, Yamagata Z, Muto K, Matsuda K, Kubo M, Nakamura Y; Biobank Japan Cooperative Hospital Group., Kiyohara Y, Ninomiya T., Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project., J Epidemiol, 10.1016/j.je.2016.10.007, 27, 3S, LEFT(Y146,FIND("-",Y146)-1)-MID(Y146,FIND("-",Y146)+1,10), 2017.03.
146. Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, Fukuhara M, Ikeda F, Shikata K, Yoshida D, Yonemoto K, Kamouchi M, Kitazono T, Kiyohara Y., Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961-2009)., Circulation, 10.1161/CIRCULATIONAHA.113.002424, 128, 11, 1198-1205, 2013.09.
147. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y., Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population., Circulation, 10.1161/CIRCULATIONAHA.107.743211, 118, 25, 2672-2678, 2008.12.
148. Furuta Y, Hata J, Mukai N, Hirakawa Y, Ago T, Kitazono T, Kiyohara Y, Ninomiya T., Secular trends in the incidence, risk factors, and prognosis of transient ischemic attack in Japan: The Hisayama Study., Atherosclerosis, 10.1016/j.atherosclerosis.2018.04.010, 273, 84-90, 2018.06.
149. Ozawa M, Ninomiya T, Ohara T, Hirakawa Y, Doi Y, Hata J, Uchida K, Shirota T, Kitazono T, Kiyohara Y., Self-reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama Study., J Am Geriatr Soc, 10.1111/j.1532-5415.2012.04061.x, 60, 8, 1515-1520, 2012.08.
150. Doi Y, Ninomiya T, Hata J, Yonemoto K, Tanizaki Y, Arima H, Liu Y, Rahman M, Iida M, Kiyohara Y., Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan., J Epidemiol, 19, 2, 56-62, 2009.01.
151. Hata J, Mukai N, Nagata M, Ohara T, Yoshida D, Kishimoto H, Shibata M, Hirakawa Y, Endo M, Ago T, Kitazono T, Oike Y, Kiyohara Y, Ninomiya T., Serum Angiopoietin-Like Protein 2 Is a Novel Risk Factor for Cardiovascular Disease in the Community: The Hisayama Study., Arterioscler Thromb Vasc Biol, 10.1161/ATVBAHA.116.307291, 36, 8, 1686-1691, 2016.08.
152. Ninomiya T, Kanzaki N, Hirakawa Y, Yoshinari M, Higashioka M, Honda T, Shibata M, Sakata S, Yoshida D, Teramoto T, Takemoto S, Nishimoto S, Hata J, Kitazono T., Serum Ethylamine Levels as an Indicator of l-Theanine Consumption and the Risk of Type 2 Diabetes in a General Japanese Population: The Hisayama Study., Diabetes Care, 10.2337/dc18-2655, 42, 7, 1234-1240, 2019.07.
153. Asada M, Oishi E, Sakata S, Hata J, Yoshida D, Honda T, Furuta Y, Shibata M, Suzuki K, Watanabe H, Murayama N, Kitazono T, Yamaura K, Ninomiya T., Serum Lipopolysaccharide-Binding Protein Levels and the Incidence of Cardiovascular Disease in a General Japanese Population: The Hisayama Study., J Am Heart Assoc, 10.1161/JAHA.119.013628, 8, 21, e013628, 2019.11.
154. Usui T, Nagata M, Hata J, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Kitazono T, Kiyohara Y, Ninomiya T., Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study., J Atheroscler Thromb, 10.5551/jat.37044, 24, 7, 706-715, 2017.07.
155. Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T., Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study., Ann Neurol, 10.1002/ana.25385, 85, 1, 47-58, 2019.01.
156. Takae K, Nagata M, Hata J, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Tsuruya K, Kitazono T, Kiyohara Y, Ninomiya T., Serum Uric Acid as a Risk Factor for Chronic Kidney Disease in a Japanese Community縲- The Hisayama Study., Circ J, 10.1253/circj.CJ-16-0030, 80, 8, 1857-1862, 2016.07.
157. Honda T, Ohara T, Shinohara M, Hata J, Toh R, Yoshida D, Shibata M, Ishida T, Hirakawa Y, Irino Y, Sakata S, Uchida K, Kitazono T, Kanba S, Hirata KI, Ninomiya T., Serum elaidic acid concentration and risk of dementia: The Hisayama Study., Neurology, 10.1212/WNL.0000000000008464, 93, 22, LEFT(Y153,FIND("-",Y153)-1)-MID(Y153,FIND("-",Y153)+1,10), 2019.11.
158. Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaテォlsson K, Markus HS; MEGASTROKE project of the International Stroke Genetics Consortium., Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study., Neurology, 10.1212/WNL.0000000000007001, 92, 9, LEFT(Y156,FIND("-",Y156)-1)-MID(Y156,FIND("-",Y156)+1,10), 2019.02.
159. Irie F, Kamouchi M, Hata J, Matsuo R, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators., Sex differences in short-term outcomes after acute ischemic stroke: the fukuoka stroke registry., Stroke, 10.1161/STROKEAHA.114.006739, 46, 2, 471-476, 2015.02.
160. Kuwashiro T, Ago T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Fukuda K, Sugimori H, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T., Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS)., Metabolism, 10.1016/j.metabol.2014.04.012, 63, 9, 1093-1103, 2014.09.
161. Higashioka M, Sakata S, Honda T, Hata J, Yoshida D, Hirakawa Y, Shibata M, Goto K, Kitazono T, Osawa H, Ninomiya T., Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community., J Atheroscler Thromb.
162. Ikeda F, Ninomiya T, Doi Y, Hata J, Fukuhara M, Matsumoto T, Kiyohara Y., Smoking cessation improves mortality in Japanese men: the Hisayama study., Tob Control, 10.1136/tc.2010.039362, 21, 4, 416-421, 2012.07.
163. Makihara N, Kamouchi M, Hata J, Matsuo R, Ago T, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators., Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry., Atherosclerosis, 10.1016/j.atherosclerosis.2013.09.017, 231, 2, 211-215, 2013.12.
164. Nagata M, Ninomiya T, Doi Y, Hata J, Ikeda F, Mukai N, Tsuruya K, Oda Y, Kitazono T, Kiyohara Y., Temporal trends in sudden unexpected death in a general population: the Hisayama study., Am Heart J, 10.1016/j.ahj.2013.02.028, 165, 6, 932-938, 2013.06.
165. Hata J, Tanizaki Y, Kiyohara Y, Kato I, Kubo M, Tanaka K, Okubo K, Nakamura H, Oishi Y, Ibayashi S, Iida M., Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study., J Neurol Neurosurg Psychiatry, 76, 3, 368-372, 2005.03.
166. Hata J, Doi Y, Ninomiya T, Tanizaki Y, Yonemoto K, Fukuhara M, Kubo M, Kitazono T, Iida M, Kiyohara Y., The effect of metabolic syndrome defined by various criteria on the development of ischemic stroke subtypes in a general Japanese population., Atherosclerosis, 10.1016/j.atherosclerosis.2009.10.044, 210, 1, 249-255, 2010.05.
167. Kuwashiro T, Kamouchi M, Ago T, Hata J, Sugimori H, Kitazono T., The factors associated with a functional outcome after ischemic stroke in diabetic patients: the Fukuoka Stroke Registry., J Neurol Sci, 10.1016/j.jns.2011.09.012, 313, 1-2, 110-114, 2012.02.
168. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group., The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008., Circulation, 10.1161/CIRCULATIONAHA.113.001470, 127, 14, 1493-1502, 2013.04.
169. Kishimoto H, Ohara T, Hata J, Ninomiya T, Yoshida D, Mukai N, Nagata M, Ikeda F, Fukuhara M, Kumagai S, Kanba S, Kitazono T, Kiyohara Y., The long-term association between physical activity and risk of dementia in the community: the Hisayama Study., Eur J Epidemiol, 10.1007/s10654-016-0125-y, 31, 3, 267-274, 2016.03.
170. Nagata M, Hata J, Hirakawa Y, Mukai N, Yoshida D, Ohara T, Kishimoto H, Kawano H, Kitazono T, Kiyohara Y, Ninomiya T., The ratio of serum eicosapentaenoic acid to arachidonic acid and riskツof cancer death in a Japanese community: The Hisayama Study., J Epidemiol, 10.1016/j.je.2017.01.004, 27, 12, 578-583, 2017.12.
171. Mukai N, Yasuda M, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, Hotta T, Koga M, Nakamura U, Kang D, Kitazono T, Kiyohara Y., Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study., Cardiovasc Diabetol, 10.1186/1475-2840-13-45, 13, 45-45, 2014.02.
172. Matsuo R, Kamouchi M, Ago T, Hata J, Shono Y, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T; FSR investigators., Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry., Geriatr Gerontol Int, 10.1111/ggi.12205, 14, 4, 954-959, 2014.10.
173. Asakawa M, Takeshita T, Furuta M, Kageyama S, Takeuchi K, Hata J, Ninomiya T, Yamashita Y., Tongue Microbiota and Oral Health Status in Community-Dwelling Elderly Adults., mSphere, 10.1128/mSphere.00332-18, 3, 4, e00332-18, 2018.08.
174. Takeuchi K, Ohara T, Furuta M, Takeshita T, Shibata Y, Hata J, Yoshida D, Yamashita Y, Ninomiya T., Tooth Loss and Risk of Dementia in the Community: the Hisayama Study., J Am Geriatr Soc, 10.1111/jgs.14791, 65, 5, LEFT(Y175,FIND("-",Y175)-1)-MID(Y175,FIND("-",Y175)+1,10), 2017.05.
175. Ohara T, Hata J, Yoshida D, Mukai N, Nagata M, Iwaki T, Kitazono T, Kanba S, Kiyohara Y, Ninomiya T., Trends in dementia prevalence, incidence, and survival rate in a Japanese community., Neurology, 10.1212/WNL.0000000000003932, 88, 20, 1925-1932, 2017.05.
176. Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, Arima H, Sasaki K, Iida M, Iwaki T, Kanba S, Kiyohara Y., Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study., Acta Psychiatr Scand, 10.1111/j.1600-0447.2010.01587.x, 122, 4, 319-325, 2010.10.
177. Ueda E, Yasuda M, Fujiwara K, Hashimoto S, Ohno-Matsui K, Hata J, Ishibashi T, Ninomiya T, Sonoda KH., Trends in the Prevalence of Myopia and Myopic Maculopathy in a Japanese Population: The Hisayama Study., Invest Ophthalmol Vis Sci, 10.1167/iovs.19-26580, 60, 8, 2781-2786, 2019.07.
178. Gotoh S, Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Fukuhara M, Ikeda F, Shikata K, Kamouchi M, Kitazono T, Kiyohara Y., Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community., Circ J, 78, 2, 403-409, 2014.01.
179. Ogata H, Hirakawa Y, Matsumoto K, Hata J, Yoshida D, Fukuyama S, Inoue H, Kitazono T, Ninomiya T, Nakanishi Y., Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study., BMJ Open, 10.1136/bmjopen-2018-023673, 9, 3, e023673, 2019.03.
180. Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, Tsuruya K, Iida M, Kiyohara Y., Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study., Nephrol Dial Transplant, 10.1093/ndt/gfq062, 25, 8, 2557-2564, 2010.08.
181. Mukai N, Hata J, Hirakawa Y, Ohara T, Yoshida D, Nakamura U, Kitazono T, Ninomiya T., Trends in the prevalence of type 2 diabetes and prediabetes in a Japanese community, 1988-2012: the Hisayama Study., Diabetol Int, 10.1007/s13340-018-0380-0, 10, 3, 198-205, 2018.11.
182. Mukai N, Doi Y, Ninomiya T, Hirakawa Y, Nagata M, Yoshida D, Hata J, Fukuhara M, Nakamura U, Kitazono T, Kiyohara Y., Trends in the prevalence of type 2 diabetes and prediabetes in community-dwelling Japanese subjects: The Hisayama Study., J Diabetes Investig, 10.1111/jdi.12136, 5, 2, 162-169, 2014.03.
183. Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Iwase M, Kiyohara Y., Two risk score models for predicting incident Type 2 diabetes in Japan., Diabet Med, 10.1111/j.1464-5491.2011.03376.x, 29, 1, 107-114, 2012.01.
184. Iida M, Ikeda F, Ninomiya T, Yonemoto K, Doi Y, Hata J, Matsumoto T, Iida M, Kiyohara Y., White blood cell count and risk of gastric cancer incidence in a general Japanese population: the Hisayama study., Am J Epidemiol, 10.1093/aje/kwr345, 175, 6, 504-510, 2012.03.
185. Hata J, Fukuhara M, Sakata S, Arima H, Hirakawa Y, Yonemoto K, Mukai N, Kitazono T, Kiyohara Y, Ninomiya T., White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study., Hypertens Res, 10.1038/hr.2017.74, 40, 11, 937-943, 2017.11.
186. Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y, Yonemoto K, Mukai N, Nagata M, Ikeda F, Matsumura K, Kitazono T, Kiyohara Y., White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study., Stroke, 10.1161/STROKEAHA.111.000704, 44, 6, 1512-1517, 2013.06.
187. NCD Risk Factor Collaboration (NCD-RisC)., Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants., Lancet, 10.1016/S0140-6736(16)31919-5, 389, 10064, 37-55, 2017.01.
188. NCD Risk Factor Collaboration (NCD-RisC)., Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults., Lancet, 10.1016/S0140-6736(17)32129-3, 390, 10113, 2627-2642, 2017.12.
189. NCD Risk Factor Collaboration (NCD-RisC)., Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants., Lancet, 10.1016/S0140-6736(16)00618-8, 387, 10027, 1513-1530, 2016.04.